These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8408554)

  • 1. Expression of feline immunodeficiency virus gag and env precursor proteins in Spodoptera frugiperda cells and their use in immunodiagnosis.
    Verschoor EJ; van Vliet AL; Egberink HF; Hesselink W; Horzinek MC; de Ronde A
    J Clin Microbiol; 1993 Sep; 31(9):2350-5. PubMed ID: 8408554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A recombinant-based feline immunodeficiency virus antibody enzyme-linked immunosorbent assay.
    Mermer B; Hillman P; Harris R; Krogmann T; Tonelli Q; Palin W; Andersen P
    Vet Immunol Immunopathol; 1992 Dec; 35(1-2):133-41. PubMed ID: 1337392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. gag- and env-specific serum antibodies in cats after natural and experimental infection with feline immunodeficiency virus.
    Rimmelzwaan GF; Siebelink KH; Broos H; Drost GA; Weijer K; van Herwijnen R; Osterhaus AD
    Vet Microbiol; 1994 Mar; 39(1-2):153-65. PubMed ID: 8203121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-existing immunity to pathogenic Listeria monocytogenes does not prevent induction of immune responses to feline immunodeficiency virus by a novel recombinant Listeria monocytogenes vaccine.
    Stevens R; Lavoy A; Nordone S; Burkhard M; Dean GA
    Vaccine; 2005 Feb; 23(12):1479-90. PubMed ID: 15670884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serological diagnosis of feline immunodeficiency virus infection based on synthetic peptides from Env glycoproteins.
    Avrameas A; Strosberg AD; Moraillon A; Sonigo P; Pancino G
    Res Virol; 1993; 144(3):209-18. PubMed ID: 7689247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of avian leukaemia virus env-gp85 in Spodoptera frugiperda cells by use of a baculovirus expression vector.
    Noteborn MH; de Boer GF; Kant A; Koch G; Bos JL; Zantema A; van der Eb AJ
    J Gen Virol; 1990 Nov; 71 ( Pt 11)():2641-8. PubMed ID: 2174957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retroviral vector-transduced cells expressing the core polyprotein induce feline immunodeficiency virus-specific cytotoxic T-lymphocytes from infected cats.
    Li J; Brown WC; Song W; Carpino MR; Wolf AM; Grant CK; Elder JH; Collisson EW
    Virus Res; 1995 Oct; 38(2-3):93-109. PubMed ID: 8578869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of gag- and env-specific cytotoxic T lymphocytes in protective immunity to feline immunodeficiency virus.
    Flynn JN; Beatty JA; Cannon CA; Stephens EB; Hosie MJ; Neil JC; Jarrett O
    AIDS Res Hum Retroviruses; 1995 Sep; 11(9):1107-13. PubMed ID: 8554908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feline immunodeficiency virus Gag- and Env-specific immune responses after vaginal versus intravenous infection.
    Burkhard MJ; Mathiason CK; Bowdre T; Hoover EA
    AIDS Res Hum Retroviruses; 2001 Dec; 17(18):1767-78. PubMed ID: 11788028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localization of the viral antigen of feline immunodeficiency virus in the lymph nodes of cats at the early stage of infection.
    Toyosaki T; Miyazawa T; Furuya T; Tomonaga K; Shin YS; Okita M; Kawaguchi Y; Kai C; Mori S; Mikami T
    Arch Virol; 1993; 131(3-4):335-47. PubMed ID: 8102229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FIV vaccine studies. I. Immune response to recombinant FIV env gene products and outcome after challenge infection.
    Lutz H; Hofmann-Lehmann R; Bauer-Pham K; Holznagel E; Tozzini F; Bendinelli M; Reubel G; Aubert A; Davis D; Cox D
    Vet Immunol Immunopathol; 1995 May; 46(1-2):103-13. PubMed ID: 7618250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A longitudinal study of feline immunodeficiency virus-specific cytotoxic T lymphocytes in experimentally infected cats, using antigen-specific induction.
    Beatty JA; Willett BJ; Gault EA; Jarrett O
    J Virol; 1996 Sep; 70(9):6199-206. PubMed ID: 8709246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analyses of the requirements for the synthesis of virus-like particles by feline immunodeficiency virus gag using baculovirus vectors.
    Morikawa S; Booth TF; Bishop DH
    Virology; 1991 Jul; 183(1):288-97. PubMed ID: 1647071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serological diagnosis of feline immunodeficiency virus infection using recombinant transmembrane glycoprotein.
    Calzolari M; Young E; Cox D; Davis D; Lutz H
    Vet Immunol Immunopathol; 1995 May; 46(1-2):83-92. PubMed ID: 7618262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of anti-gag antibodies of feline immunodeficiency virus in cat sera by enzyme-linked immunosorbent assay.
    Furuya T; Hasegawa A; Miyazawa T; Miki K; Mikami T
    Arch Virol; 1992; 124(3-4):355-61. PubMed ID: 1318710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on processing, particle formation, and immunogenicity of the HIV-1 gag gene product: a possible component of a HIV vaccine.
    Wagner R; Fliessbach H; Wanner G; Motz M; Niedrig M; Deby G; von Brunn A; Wolf H
    Arch Virol; 1992; 127(1-4):117-37. PubMed ID: 1456888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunodiagnosis of feline immunodeficiency virus infection using recombinant viral p17 and p24.
    Reid G; Rigby MA; McDonald M; Hosie MJ; Neil JC; Jarrett O
    AIDS; 1991 Dec; 5(12):1477-83. PubMed ID: 1667575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in Env and Gag protein expression patterns and epitope availability in feline immunodeficiency virus infected PBMC compared to infected and transfected feline model cell lines.
    Roukaerts IDM; Grant CK; Theuns S; Christiaens I; Acar DD; Van Bockstael S; Desmarets LMB; Nauwynck HJ
    Virus Res; 2017 Jan; 227():249-260. PubMed ID: 27836726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gag-specific immune enhancement of lentiviral infection after vaccination with an adenoviral vector in an animal model of AIDS.
    Klonjkowski B; Klein D; Galea S; Gavard F; Monteil M; Duarte L; Fournier A; Sayon S; Górna K; Ertl R; Cordonnier N; Sonigo P; Eloit M; Richardson J
    Vaccine; 2009 Feb; 27(6):928-39. PubMed ID: 19070641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization trial of cats with a replication-defective adenovirus type 5 expressing the ENV gene of feline immunodeficiency virus.
    Gonin P; Fournier A; Oualikene W; Moraillon A; Eloit M
    Vet Microbiol; 1995 Aug; 45(4):393-401. PubMed ID: 7483252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.